Latest news
CRL: Raised guidance after strong Q2 results, margin gains, and robust DSA bookings - TradingViewTradingView · Wed, 05 Aug 2026 16:19:08 GMTCRL: Q2 2026 revenue fell 2.7% YoY, but operating margin rose to 11.9% amid portfolio shifts - TradingViewTradingView · Wed, 05 Aug 2026 13:23:07 GMTCRL: 2Q26 organic revenue and EPS beat outlook, prompting raised 2026 guidance and margin expansion - TradingViewTradingView · Wed, 05 Aug 2026 11:18:18 GMTCRL: Double-digit growth across all segments and regions, with EBITDA margin up 350 bps year-over-year - TradingViewTradingView · Tue, 04 Aug 2026 17:11:38 GMTCRL: H1 2026 saw record revenue, margin expansion, and strategic M&A, with robust growth expected to continue - TradingViewTradingView · Tue, 04 Aug 2026 14:31:57 GMTCRL: Revenue up 20.9% and net profit up 72.5% in H1 2026, driven by broad-based segment growth - TradingViewTradingView · Tue, 04 Aug 2026 13:47:26 GMTCRL Q2'26 Earnings: EPS estimate is 2.74 USD - TradingViewTradingView · Tue, 04 Aug 2026 11:00:36 GMTCharles River Laboratories Earnings: What To Look For From CRL - TradingViewTradingView · Tue, 04 Aug 2026 03:22:00 GMT